Insider Buying Mark Mckenna Acquires 20,000 Shares of Apogee Therapeutics Inc
APGE Stock | 47.71 0.69 1.47% |
About 54% of Apogee Therapeutics,'s investor base is interested to short. The analysis of the overall investor sentiment regarding Apogee Therapeutics, Common suggests that many traders are impartial. The current market sentiment, together with Apogee Therapeutics,'s historical and current headlines, can help investors time the market. In addition, many technical investors use Apogee Therapeutics, stock news signals to limit their universe of possible portfolio assets.
Apogee |
On December 12, 2024, Mark Mckenna, a Director at Apogee Therapeutics Inc , purchased 20,000 shares of the company, according to a SEC Filing. Following t
Read at gurufocus.com
Apogee Therapeutics, Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Apogee Therapeutics, can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Apogee Therapeutics, Fundamental Analysis
We analyze Apogee Therapeutics,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Apogee Therapeutics, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Apogee Therapeutics, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Working Capital
Working Capital Comparative Analysis
Apogee Therapeutics, is currently under evaluation in working capital category among its peers. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
Apogee Therapeutics, Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Apogee Therapeutics, stock to make a market-neutral strategy. Peer analysis of Apogee Therapeutics, could also be used in its relative valuation, which is a method of valuing Apogee Therapeutics, by comparing valuation metrics with similar companies.
Peers
Apogee Therapeutics, Related Equities
LCID | Lucid | 14.83 | ||||
SPHR | Sphere Entertainment | 5.19 | ||||
RDCM | Radcom | 2.77 | ||||
BWA | BorgWarner | 1.27 | ||||
MPX | Marine Products | 0.97 | ||||
NCMI | National CineMedia | 0.30 | ||||
WNC | Wabash National | 0.53 | ||||
GNTX | Gentex | 0.55 |
Complementary Tools for Apogee Stock analysis
When running Apogee Therapeutics,'s price analysis, check to measure Apogee Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apogee Therapeutics, is operating at the current time. Most of Apogee Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Apogee Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apogee Therapeutics,'s price. Additionally, you may evaluate how the addition of Apogee Therapeutics, to your portfolios can decrease your overall portfolio volatility.
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |